<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="alagille" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">alagille</book-part-id>
      <title-group>
        <title>Alagille Syndrome</title>
        <alt-title alt-title-type="alt-title">Synonyms: Arteriohepatic Dysplasia, Syndromic Bile Duct Paucity</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Spinner</surname>
            <given-names>Nancy B</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Professor of Pathology and Laboratory Medicine, Perelman School of Medicine<break/>University of Pennsylvania<break/>Professor of Pediatrics, Children's Hospital of Philadelphia<break/>Philadelphia, Pennsylvania</aff>
          <email>spinner@mail.med.upenn.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Leonard</surname>
            <given-names>Laura D</given-names>
          </name>
          <degrees>BA</degrees>
          <aff>Clinical Research Assistant, Children&#x02019;s Hospital of Philadelphia<break/>Philadelphia, Pennsylvania</aff>
          <email>leonardl@email.chop.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Krantz</surname>
            <given-names>Ian D</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Professor of Pediatrics and Genetics, Perelman School of Medicine<break/>University of Pennsylvania School of Medicine and Children's Hospital of Philadelphia<break/>Philadelphia, Pennsylvania</aff>
          <email>ian2@mail.med.upenn.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2000-05-19" date-type="created">
          <day>19</day>
          <month>5</month>
          <year>2000</year>
        </date>
        <date iso-8601-date="2013-02-28" date-type="updated">
          <day>28</day>
          <month>2</month>
          <year>2013</year>
        </date>
        <date iso-8601-date="2010-07-20" date-type="revised">
          <day>20</day>
          <month>7</month>
          <year>2010</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="ags" document-type="chapter">Aicardi-Gouti&#x000e8;res Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="alexander" document-type="chapter">Alexander Disease</related-object>
      <abstract id="alagille.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Alagille syndrome (ALGS) is a complex multisystem disorder involving primarily the liver, heart, eyes, face, and skeleton. The clinical features are highly variable, even within families. The major clinical manifestations of ALGS are cholestasis, characterized by bile duct paucity on liver biopsy; congenital cardiac defects, primarily involving the pulmonary arteries; posterior embryotoxon in the eye; typical facial features; and butterfly vertebrae. Renal and central nervous abnormalities also occur. Mortality is approximately 10%, with vascular accidents, cardiac disease, and liver disease accounting for most of the deaths.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of ALGS is primarily based on clinical findings. The two genes in which mutation is known to cause ALGS are <italic toggle="yes">JAG1</italic> and <italic toggle="yes">NOTCH2</italic>. Sequence analysis of <italic toggle="yes">JAG1</italic> detects pathogenic variants in more than 89% of individuals who meet clinical diagnostic criteria; deletion/duplication analysis detects exon and whole-gene deletions, including microdeletion of 20p12, in approximately 7% of affected individuals. Pathogenic variants in <italic toggle="yes">NOTCH2</italic> are observed in 1%-2% of individuals with ALGS.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations</italic>: Management by a multidisciplinary team (medical genetics, gastroenterology, nutrition, cardiology, ophthalmology, nephrology, liver transplantation); choloretic agents (ursodeoxycholic acid), other medications (cholestyramine, rifampin, naltrexone), and, when necessary, partial external biliary diversion or ileal exclusions for pruritis and xanthomas; liver transplantation for end-stage liver disease; standard treatment for cardiac, renal, and neurologic involvement.</p>
          <p><italic toggle="yes">Prevention of secondary complications</italic>: Optimization of nutrition to maximize growth and development; fat-soluble vitamin supplementation; for those with splenomegaly or with chronic liver disease, use of a spleen guard during activities.</p>
          <p><italic toggle="yes">Surveillance</italic>: Routine monitoring of growth, nutrition, and heart.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid</italic>: Contact sports; alcohol if liver disease is present.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk</italic>: Offer molecular genetic testing to first-degree relatives if the family-specific pathogenic variant is known or assess first-degree relatives for disease manifestations.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>ALGS is inherited in an autosomal dominant manner. Approximately 30%-50% of individuals have an inherited pathogenic variant and about 50%-70% have a <italic toggle="yes">de novo</italic> pathogenic variant. For parents of a child with an apparent <italic toggle="yes">de novo</italic> pathogenic variant, recurrence risk to subsequent offspring of having Alagille syndrome is low but greater than in the general population because of the possibility of germline mosaicism. The offspring of an individual with Alagille syndrome have a 50% chance of having Alagille syndrome. Prenatal testing for pregnancies at increased risk is possible if the pathogenic variant in an affected family member is known. Prenatal testing cannot predict the occurrence or severity of clinical manifestations.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="alagille.Diagnosis">
        <title>Diagnosis</title>
        <sec id="alagille.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The clinical diagnostic criteria for Alagille syndrome (ALGS) include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>The histologic finding of bile duct paucity</bold> (an increased portal tract-to-bile duct ratio) on liver biopsy. Although considered to be the most important and constant feature of ALGS, bile duct paucity is not present in infancy in many individuals ultimately shown to have ALGS. In the newborn, a normal ratio of portal tracts to bile ducts, bile duct proliferation, or a picture suggestive of neonatal hepatitis may be observed. Overall, bile duct paucity is present in about 90% of individuals.</p>
            </list-item>
            <list-item>
              <p><bold>Three of the following five major clinical features</bold> (in addition to bile duct paucity):</p>
              <list list-type="bullet">
                <list-item>
                  <p>Cholestasis</p>
                </list-item>
                <list-item>
                  <p>Cardiac defect (most commonly stenosis of the peripheral pulmonary artery and its branches)</p>
                </list-item>
                <list-item>
                  <p>Skeletal abnormalities (most commonly butterfly vertebrae identified in AP chest radiographs)</p>
                </list-item>
                <list-item>
                  <p>Ophthalmologic abnormalities (most commonly posterior embryotoxon)</p>
                </list-item>
                <list-item>
                  <p>Characteristic facial features</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>In addition, abnormalities of the kidney, neurovasculature, and pancreas are important manifestations of Alagille syndrome [<xref ref-type="bibr" rid="alagille.REF.kamath.2012b.85">Kamath et al 2012b</xref>, <xref ref-type="bibr" rid="alagille.REF.turnpenny.2012.251">Turnpenny &#x00026; Ellard 2012</xref>].</p>
          <p>Note: The diagnosis of Alagille syndrome may be difficult because of the highly variable expressivity of the clinical manifestations [<xref ref-type="bibr" rid="alagille.REF.goldman.2011.193">Goldman &#x00026; Pranikoff 2011</xref>, <xref ref-type="bibr" rid="alagille.REF.guegan.2012.33">Guegan et al 2012</xref>].</p>
          <p><bold>Individuals with an affected relative.</bold> The diagnosis of ALGS should be considered in individuals who do not meet the full clinical criteria but do have an affected relative. If an affected first-degree relative is identified, the presence of one or more features is considered sufficient to make the diagnosis on clinical grounds.</p>
        </sec>
        <sec id="alagille.Molecular_Genetic_Testing">
          <title>Molecular Genetic Testing</title>
          <p>
            <bold>Genes</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Pathogenic variants in <italic toggle="yes">JAG1</italic> are known to cause about 94%-96% of cases of ALGS.</p>
            </list-item>
            <list-item>
              <p>Pathogenic variants in <italic toggle="yes">NOTCH2</italic> are known to cause ALGS in 1%-2% of individuals [<xref ref-type="bibr" rid="alagille.REF.mcdaniell.2006.169">McDaniell et al 2006</xref>, <xref ref-type="bibr" rid="alagille.REF.kamath.2012a.138">Kamath et al 2012a</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Clinical testing</bold>
          </p>
          <table-wrap id="alagille.T.summary_of_molecular_genetic" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Alagille Syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_2" valign="top" align="left" scope="col" rowspan="1" colspan="1">Proportion of ALGS Attributed to Mutation of This Gene</th>
                  <th id="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variants Detected&#x000a0;<sup>2</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_1" rowspan="4" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">JAG1</italic>
                  </td>
                  <td headers="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">89%</td>
                  <td headers="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup> / scanning for pathogenic variants&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                </tr>
                <tr>
                  <td headers="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_2" valign="top" colspan="1" align="left" scope="row" rowspan="1">See footnote 5</td>
                  <td headers="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis of select exons&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants in select exons</td>
                </tr>
                <tr>
                  <td headers="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_2" valign="top" colspan="1" align="left" scope="row" rowspan="1">~5%-7%&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Deletion/duplication analysis (including FISH)&#x000a0;<sup>7</sup></td>
                  <td headers="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Deletion and duplication of exon(s) and entire gene deletion&#x000a0;<sup>8</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_2" valign="top" colspan="1" align="left" scope="row" rowspan="1">Linkage analysis</td>
                  <td headers="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  <td headers="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">See footnote 9</td>
                </tr>
                <tr>
                  <td headers="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">NOTCH2</italic>
                  </td>
                  <td headers="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">1%-2%&#x000a0;<sup>10</sup></td>
                  <td headers="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                </tr>
                <tr>
                  <td headers="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Unknown</td>
                  <td headers="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>7</sup></td>
                  <td headers="hd_h_alagille.T.summary_of_molecular_genetic_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Unknown, none reported</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="alagille.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="alagille" object-id="alagille.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="alagille.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="alagille.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
              </fn>
              <fn id="alagille.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="alagille.TF.1.4">
                <label>4. </label>
                <p>Sequence analysis and mutation scanning of the entire gene can have similar mutation detection frequencies; however, variant detection rates for variant scanning may vary considerably between laboratories depending on the specific protocol used.</p>
              </fn>
              <fn id="alagille.TF.1.5">
                <label>5. </label>
                <p>Dependent on exons sequenced and methodologies used. Two thirds of the detectable pathogenic variants are identified by sequencing exons 1-6, 9, 12, 17, 20, 23, and 24.</p>
              </fn>
              <fn id="alagille.TF.1.6">
                <label>6. </label>
                <p><xref ref-type="bibr" rid="alagille.REF.warthen.2006.436">Warthen et al [2006]</xref>, personal communication. Extent of deletion detected may vary by method and by laboratory.</p>
              </fn>
              <fn id="alagille.TF.1.7">
                <label>7. </label>
                <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="alagille.TF.1.8">
                <label>8. </label>
                <p>Extent of deletion detected may vary by method and by laboratory [<xref ref-type="bibr" rid="alagille.REF.kamath.2009.371">Kamath et al 2009</xref>].</p>
              </fn>
              <fn id="alagille.TF.1.9">
                <label>9. </label>
                <p>Linkage analysis may be performed if the family pedigree structure is sufficient and family members agree to the testing process (1) to confirm cosegregation of a potential pathogenic variant with disease in individual families and (2) as an ancillary test to obtain preliminary data prior to the completion of sequence analysis. Linkage testing cannot be used to confirm the diagnosis of Alagille syndrome.</p>
              </fn>
              <fn id="alagille.TF.1.10">
                <label>10. </label>
                <p><xref ref-type="bibr" rid="alagille.REF.mcdaniell.2006.169">McDaniell et al [2006]</xref>, <xref ref-type="bibr" rid="alagille.REF.kamath.2012a.138">Kamath et al [2012a]</xref></p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="alagille.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>Test characteristics.</bold> See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/ejhg/journal/v22/n3/full/ejhg2013140a.html">Clinical Utility Gene Card</ext-link> [<xref ref-type="bibr" rid="alagille.REF.leonard.2014">Leonard et al 2014</xref>] for information on test characteristics including sensitivity and specificity.</p>
          <p>
            <bold>To confirm/establish the diagnosis of ALGS in a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>In situations in which the diagnosis is suspected but the criteria for clinical diagnosis are not met, sequence analysis of <italic toggle="yes">JAG1</italic> should be performed first, as this identifies pathogenic variants in more than 89% of persons with a <italic toggle="yes">JAG1</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>If no pathogenic variants are detected by sequence analysis of <italic toggle="yes">JAG1</italic>, deletion/duplication analysis can be performed to detect deletions or duplications of <italic toggle="yes">JAG1</italic> exon(s) or of the whole gene. Given the wide availability of targeted CMA testing, this could be used to determine both the presence and extent of a chromosome deletion/duplication involving <italic toggle="yes">JAG1</italic> if there was high density of probes in the region. Other deletion/duplication methods (e.g., MLPA) also detect exon or whole-gene deletions.</p>
            </list-item>
            <list-item>
              <p>If a deletion involving the entire <italic toggle="yes">JAG1</italic> gene is identified, a full cytogenetic study may be considered to determine if a rare chromosome rearrangement (translocation or inversion) is present.</p>
            </list-item>
            <list-item>
              <p>The presence of developmental delay and/or hearing loss in addition to the features commonly seen in ALGS may increase the suspicion of a chromosome deletion.</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">NOTCH2</italic> molecular genetic testing should be considered when the diagnosis is strongly suspected on clinical grounds, but no <italic toggle="yes">JAG1</italic> variant/deletion/duplication was identified.</p>
            </list-item>
          </list>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for pregnancies at risk for ALGS require prior identification of the pathogenic variant in the family.</p>
        </sec>
      </sec>
      <sec id="alagille.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="alagille.Clinical_Description">
          <title>Clinical Description</title>
          <p>Alagille syndrome (ALGS) is a multisystem disorder. Studies of families with multiple affected members and/or <italic toggle="yes">JAG1</italic> pathogenic variants have demonstrated a wide spectrum of clinical variability ranging from life-threatening liver or cardiac disease to only subclinical manifestations (i.e., butterfly vertebrae, posterior embryotoxon, or characteristic facial features). This variability is seen even among individuals from the same family [<xref ref-type="bibr" rid="alagille.REF.kamath.2003.891">Kamath et al 2003</xref>]. Indeed, in a study of 53 <italic toggle="yes">JAG1</italic> variant-confirmed relatives of affected individuals, 25 (47%) did not meet clinical diagnostic criteria [<xref ref-type="bibr" rid="alagille.REF.kamath.2003.891">Kamath et al 2003</xref>].</p>
          <p>Individuals with ALGS who have severe liver or cardiac involvement are most often diagnosed in infancy. In those individuals with subclinical or mild hepatic manifestations, the diagnosis may not be established until later in life.</p>
          <p>Mortality in ALGS is approximately 10%, with early mortality caused by cardiac disease or severe liver disease, and later mortality often caused by vascular accidents [<xref ref-type="bibr" rid="alagille.REF.emerick.1999.822">Emerick et al 1999</xref>, <xref ref-type="bibr" rid="alagille.REF.kamath.2004.1354">Kamath et al 2004</xref>].</p>
          <p>Two studies by <xref ref-type="bibr" rid="alagille.REF.emerick.1999.822">Emerick et al [1999]</xref> and <xref ref-type="bibr" rid="alagille.REF.subramaniam.2011.84">Subramaniam et al [2011]</xref> discuss the frequency of clinical manifestations in individuals with ALGS (<xref ref-type="table" rid="alagille.T.clinical_manifestations_of_al">Table 2</xref>).</p>
          <table-wrap id="alagille.T.clinical_manifestations_of_al" position="anchor" orientation="portrait">
            <label>Table 2. </label>
            <caption>
              <p>Clinical Manifestations of ALGS in Two Studies</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_1">Clinical Finding</th>
                  <th id="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Frequency (% of Individuals)</th>
                </tr>
                <tr>
                  <th headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2" id="hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">
                    <xref ref-type="bibr" rid="alagille.REF.emerick.1999.822">Emerick et al [1999]</xref>
                  </th>
                  <th headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2" id="hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="alagille.REF.subramaniam.2011.84">Subramaniam et al [2011]</xref>
                  </th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Bile duct paucity</td>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2 hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">69/81 (85%)</td>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2 hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">77/103 (75%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Chronic cholestasis</td>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2 hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">88/92 (96%)</td>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2 hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">104/117 (89%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Cardiac murmur</td>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2 hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">90/92 (97%)</td>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2 hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">107/117 (91%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Eye findings</td>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2 hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">65/83 (78%)</td>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2 hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">72/117 (61%)&#x000a0;<sup>1</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Vertebral anomalies</td>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2 hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">37/71 (51%)</td>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2 hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">44/117 (39%)&#x000a0;<sup>2</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Characteristic facies</td>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2 hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">86/92 (96%)</td>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2 hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">91/117 (77%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Renal disease</td>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2 hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">28/69 (40%)</td>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2 hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">27/117 (23%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Pancreatic insufficiency</td>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2 hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">7/17 (41%)</td>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2 hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                </tr>
                <tr>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Growth retardation</td>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2 hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">27/31 (87%)</td>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2 hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                </tr>
                <tr>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Intellectual disability</td>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2 hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">2/92 (2%)</td>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2 hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                </tr>
                <tr>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Developmental delay</td>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2 hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">15/92 (16%)</td>
                  <td headers="hd_h_alagille.T.clinical_manifestations_of_al_1_1_1_2 hd_h_alagille.T.clinical_manifestations_of_al_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">NR</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Based on 92 individuals with ALGS [<xref ref-type="bibr" rid="alagille.REF.emerick.1999.822">Emerick et al 1999</xref>] and 117 children with ALGS [<xref ref-type="bibr" rid="alagille.REF.subramaniam.2011.84">Subramaniam et al 2011</xref>]</p>
              </fn>
              <fn>
                <p>NR = Not reviewed.</p>
              </fn>
              <fn id="alagille.TF.2.1">
                <label>1. </label>
                <p>Only posterior embryotoxon was reviewed in this study.</p>
              </fn>
              <fn id="alagille.TF.2.2">
                <label>2. </label>
                <p>Only butterfly vertebrae was reviewed in this study.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Hepatic manifestations.</bold> Although some individuals with <italic toggle="yes">JAG1</italic> pathogenic variants have no detectable hepatic manifestations [<xref ref-type="bibr" rid="alagille.REF.gurkan.1999.416">Gurkan et al 1999</xref>, <xref ref-type="bibr" rid="alagille.REF.krantz.1999.56">Krantz et al 1999</xref>, <xref ref-type="bibr" rid="alagille.REF.kamath.2003.891">Kamath et al 2003</xref>], in most affected persons liver disease presents within the first three months of life and ranges from jaundice, mild cholestasis, and pruritis to progressive liver failure.</p>
          <p>Jaundice presents as conjugated hyperbilirubinemia in the neonatal period. Increased serum concentrations of bile acids, alkaline phosphatase, gamma-glutamyl transpeptidase (GGT), triglycerides, and the aminotransferases are also seen.</p>
          <p>Cholestasis manifests as pruritis, increased serum concentration of bile acids, growth failure, and xanthomas.</p>
          <p>In approximately 15% of affected individuals, the liver disease progresses to cirrhosis and liver failure, necessitating liver transplantation [<xref ref-type="bibr" rid="alagille.REF.emerick.1999.822">Emerick et al 1999</xref>]. Currently, it is not possible to predict which infants will progress to end-stage liver disease.</p>
          <p>Liver biopsy typically shows paucity of the intrahepatic bile ducts, which may be progressive. In the newborn with ALGS, bile duct paucity is not always present and the liver biopsy may demonstrate ductal proliferation, resulting in the possible misdiagnosis of ALGS as biliary atresia.</p>
          <p>While it is difficult to predict whether a child with cholestasis will have improvement or progression of liver disease, a retrospective study of 33 individuals with Alagille syndrome found that in children younger than age five years, a total bilirubin &#x0003e;6.5 mg/dL, a conjugated bilirubin &#x0003e;4.5 mg/dL and a cholesterol &#x0003e;520 mg/dL were associated with severe liver disease later in life. These biomarkers and suggested cutoff values can be used to inform medical management and may help identify affected individuals who would benefit from more aggressive therapy [<xref ref-type="bibr" rid="alagille.REF.kamath.2010b.526">Kamath et al 2010b</xref>].</p>
          <p><bold>Cardiac manifestations.</bold> Cardiac findings ranging from benign heart murmurs to significant structural defects occur in 90%-97% of individuals with ALGS [<xref ref-type="bibr" rid="alagille.REF.emerick.1999.822">Emerick et al 1999</xref>, <xref ref-type="bibr" rid="alagille.REF.mcelhinney.2002.2567">McElhinney et al 2002</xref>]. The pulmonary vasculature (pulmonary valve, pulmonary artery, and its branches) is most commonly involved. Pulmonic stenosis (peripheral and branch) is the most common cardiac finding (67%) [<xref ref-type="bibr" rid="alagille.REF.emerick.1999.822">Emerick et al 1999</xref>]. The most common complex cardiac defect is tetralogy of Fallot, seen in 7%-16% of individuals [<xref ref-type="bibr" rid="alagille.REF.emerick.1999.822">Emerick et al 1999</xref>]. Other cardiac malformations include (in order of decreasing frequency) ventricular septal defect, atrial septal defect, aortic stenosis, and coarctation of the aorta.</p>
          <p><bold>Ophthalmologic manifestations.</bold> The most common ophthalmologic finding in individuals with ALGS is posterior embryotoxon. Posterior embryotoxon, a prominent Schwalbe's ring, is a defect of the anterior chamber of the eye and has been reported in 78%-89% of individuals with ALGS [<xref ref-type="bibr" rid="alagille.REF.emerick.1999.822">Emerick et al 1999</xref>, <xref ref-type="bibr" rid="alagille.REF.hingorani.1999.330">Hingorani et al 1999</xref>]. Most accurately identified on slit-lamp examination, posterior embryotoxon does not affect visual acuity but is useful as a diagnostic aid. Posterior embryotoxon is also present in approximately 8%-15% of individuals from the general population. This finding in family members who are otherwise unaffected can complicate the identification of relatives with the pathogenic variant.</p>
          <p>Other defects of the anterior chamber seen in ALGS include Axenfeld anomaly and Rieger anomaly. Ocular ultrasonographic examination in 20 children with ALGS found optic disk drusen in 90%. Retinal pigmentary changes are also common (32% in one study) [<xref ref-type="bibr" rid="alagille.REF.hingorani.1999.330">Hingorani et al 1999</xref>, <xref ref-type="bibr" rid="alagille.REF.elkoofy.2011.199">El-Koofy et al 2011</xref>]. Although these changes were initially thought to be the result of dietary deficiency, they have been seen in individuals with normal serum concentrations of vitamins A and E [<xref ref-type="bibr" rid="alagille.REF.hingorani.1999.330">Hingorani et al 1999</xref>]. Additionally eye anomalies have also been described [<xref ref-type="bibr" rid="alagille.REF.makino.2012.1445">Makino et al 2012</xref>].</p>
          <p>The visual prognosis is good, although mild decreases in visual acuity may occur. In particular, visual loss has been described in association with intracranial hypertension [<xref ref-type="bibr" rid="alagille.REF.narula.2006.348">Narula et al 2006</xref>].</p>
          <p><bold>Skeletal manifestations.</bold> The most common radiographic finding is butterfly vertebrae, a clefting abnormality of the vertebral bodies that occurs most commonly in the thoracic vertebrae. The frequency of butterfly vertebrae reported in individuals with ALGS ranges from 33% to 93% [<xref ref-type="bibr" rid="alagille.REF.emerick.1999.822">Emerick et al 1999</xref>, <xref ref-type="bibr" rid="alagille.REF.sanderson.2002.114">Sanderson et al 2002</xref>, <xref ref-type="bibr" rid="alagille.REF.lin.2012.1005">Lin et al 2012</xref>]. Butterfly vertebrae are usually asymptomatic. The incidence in the general population is unknown but suspected to be low. Other skeletal manifestations in individuals with ALGS have been reported less frequently [<xref ref-type="bibr" rid="alagille.REF.zanotti.2012.886">Zanotti &#x00026; Canalis 2012</xref>].</p>
          <p><bold>Facial features.</bold> The constellation of facial features observed in children with ALGS includes a prominent forehead, deep-set eyes with moderate hypertelorism, pointed chin, and saddle or straight nose with a bulbous tip. These features give the face the appearance of an inverted triangle. The typical facial features are almost universally present in Alagille syndrome (see <xref ref-type="fig" rid="alagille.F1">Figure 1</xref>).</p>
          <p>Although the facial phenotype in ALGS is specific to the syndrome and is often a powerful diagnostic tool, Lin et al showed that North American dysmorphologists had difficulty assessing the facial features in a cohort of Vietnamese children with Alagille syndrome, suggesting that the value of this diagnostic tool is variable across populations [<xref ref-type="bibr" rid="alagille.REF.lin.2012.1005">Lin et al 2012</xref>].</p>
          <p>
            <bold>Other features</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Renal abnormalities, both structural (small hyperechoic kidney, ureteropelvic obstruction, renal cysts) and functional (most commonly renal tubular acidosis), found in 39% of affected individuals (73/187) [<xref ref-type="bibr" rid="alagille.REF.kamath.2012b.85">Kamath et al 2012b</xref>]. Hypertension and renal artery stenosis have also been noted in adults with ALGS [<xref ref-type="bibr" rid="alagille.REF.salem.2012.1300">Salem et al 2012</xref>].</p>
            </list-item>
            <list-item>
              <p>Pancreatic insufficiency [<xref ref-type="bibr" rid="alagille.REF.emerick.1999.822">Emerick et al 1999</xref>]</p>
            </list-item>
            <list-item>
              <p>Growth failure (50%-90%) [<xref ref-type="bibr" rid="alagille.REF.emerick.1999.822">Emerick et al 1999</xref>, <xref ref-type="bibr" rid="alagille.REF.arvay.2005.146">Arvay et al 2005</xref>]</p>
            </list-item>
            <list-item>
              <p>Mild delays of gross motor skills, identified in 16% of affected individuals. Whereas initial reports suggested that intellectual disability was present in 30% of affected individuals, mild intellectual disability was subsequently identified in only 2% [<xref ref-type="bibr" rid="alagille.REF.emerick.1999.822">Emerick et al 1999</xref>]. This decreased incidence is attributed to more aggressive nutritional management and intervention.</p>
            </list-item>
            <list-item>
              <p>Neurovascular accidents, reported at rates as high as 15% [<xref ref-type="bibr" rid="alagille.REF.emerick.1999.822">Emerick et al 1999</xref>] and accounting for 34% of mortality in one large study [<xref ref-type="bibr" rid="alagille.REF.kamath.2004.1354">Kamath et al 2004</xref>]. Renovascular anomalies, middle aortic syndrome, and moyamoya syndrome [<xref ref-type="bibr" rid="alagille.REF.woolfenden.1999.505">Woolfenden et al 1999</xref>, <xref ref-type="bibr" rid="alagille.REF.rocha.2012.125">Rocha et al 2012</xref>] have been reported. Anomalies of the basilar, carotid, and middle cerebral arteries also occur [<xref ref-type="bibr" rid="alagille.REF.kamath.2004.1354">Kamath et al 2004</xref>, <xref ref-type="bibr" rid="alagille.REF.emerick.2005.99">Emerick et al 2005</xref>].</p>
            </list-item>
            <list-item>
              <p>Delayed puberty and high-pitched voice</p>
            </list-item>
            <list-item>
              <p>Extra digital flexion crease [<xref ref-type="bibr" rid="alagille.REF.kamath.2002a.171">Kamath et al 2002a</xref>]</p>
            </list-item>
            <list-item>
              <p><related-object link-type="booklink" source-id="gene" document-id="craniosynostosis" document-type="chapter">Craniosynostosis</related-object> [<xref ref-type="bibr" rid="alagille.REF.kamath.2002b.176">Kamath et al 2002b</xref>]</p>
            </list-item>
            <list-item>
              <p>Fractures of the lower extremities [<xref ref-type="bibr" rid="alagille.REF.bales.2010.66">Bales et al 2010</xref>]</p>
            </list-item>
          </list>
        </sec>
        <sec id="alagille.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>The phenotype of ALGS caused by mutation of <italic toggle="yes">JAG1</italic> is indistinguishable from the phenotype caused by mutation of <italic toggle="yes">NOTCH2</italic>. Initially, 3/3 relatives who had pathogenic variants in <italic toggle="yes">NOTCH2</italic> had significant renal disease, often resulting in end-stage renal disease [<xref ref-type="bibr" rid="alagille.REF.mcdaniell.2006.169">McDaniell et al 2006</xref>]. More recent studies have shown that renal involvement was noted in 4/9 affected individuals evaluated for renal anomalies. This observation is consistent with the renal involvement observed in those with <italic toggle="yes">JAG1</italic> pathogenic variants. However, it is important to note that the number of individuals identified with ALGS caused by mutation of <italic toggle="yes">NOTCH2</italic> is still too small to draw any conclusions about genotype-phenotype correlations [<xref ref-type="bibr" rid="alagille.REF.kamath.2012a.138">Kamath et al 2012a</xref>].</p>
          <p>No genotype-phenotype correlations exist between clinical manifestations of ALGS and specific <italic toggle="yes">JAG1</italic> pathogenic variant types or location within the gene [<xref ref-type="bibr" rid="alagille.REF.krantz.1998.1361">Krantz et al 1998</xref>, <xref ref-type="bibr" rid="alagille.REF.crosnier.1999.1141">Crosnier et al 1999</xref>, <xref ref-type="bibr" rid="alagille.REF.spinner.2001.18">Spinner et al 2001</xref>, <xref ref-type="bibr" rid="alagille.REF.mcelhinney.2002.2567">McElhinney et al 2002</xref>]. However, two families with <italic toggle="yes">JAG1</italic> pathogenic missense variants in which cardiac disease was segregating in the absence of liver disease have been reported [<xref ref-type="bibr" rid="alagille.REF.eldadah.2001.163">Eldadah et al 2001</xref>, <xref ref-type="bibr" rid="alagille.REF.le_caignec.2002.180">Le Caignec et al 2002</xref>]. Molecular analysis of one of the families demonstrated a 'leaky' pathogenic variant, in which the amount of Jagged1 protein produced appeared to fall between that seen in an individual with haploinsufficiency and an individual with two normal copies of <italic toggle="yes">JAG1</italic>, suggesting that the heart is more sensitive to <italic toggle="yes">JAG1</italic> dosage than the liver [<xref ref-type="bibr" rid="alagille.REF.eldadah.2001.163">Eldadah et al 2001</xref>, <xref ref-type="bibr" rid="alagille.REF.lu.2003.1065">Lu et al 2003</xref>].</p>
          <p>Individuals with ALGS with more severe impairment may have a larger deletion of chromosome 20p12 encompassing the entire <italic toggle="yes">JAG1</italic> gene as well as other genes in the region.</p>
        </sec>
        <sec id="alagille.Penetrance">
          <title>Penetrance</title>
          <p>ALGS demonstrates highly variable expressivity with clinical features ranging from subclinical to severe.</p>
          <p><bold><italic toggle="yes">JAG1</italic> pathogenic variants.</bold> To determine the range and frequency of clinical findings in individuals with a <italic toggle="yes">JAG1</italic> pathogenic variant and hence, the penetrance, <xref ref-type="bibr" rid="alagille.REF.kamath.2003.891">Kamath et al [2003]</xref> studied 53 <italic toggle="yes">JAG1</italic> variant-confirmed relatives of probands with ALGS. Their findings:</p>
          <list list-type="bullet">
            <list-item>
              <p>21% met diagnostic criteria independent of family history.</p>
            </list-item>
            <list-item>
              <p>32% were asymptomatic, but met clinical diagnostic criteria when additional testing was performed (analysis of liver enzymes, cardiac examination, eye examination, or skeletal x-rays).</p>
            </list-item>
            <list-item>
              <p>43% had one or two features of ALGS.</p>
            </list-item>
            <list-item>
              <p>4% had no features of ALGS.</p>
            </list-item>
          </list>
          <p>Based on these data, penetrance is 96%; however, only 53% meet clinical diagnostic criteria for ALGS.</p>
          <p><bold><italic toggle="yes">NOTCH2</italic> pathogenic variants.</bold> Penetrance appears complete in the ten individuals so far identified with <italic toggle="yes">NOTCH2</italic> pathogenic variants, although expressivity is variable [<xref ref-type="bibr" rid="alagille.REF.kamath.2012a.138">Kamath et al 2012a</xref>].</p>
        </sec>
        <sec id="alagille.Anticipation">
          <title>Anticipation</title>
          <p>ALGS has not shown anticipation. Bias of ascertainment may occur because individuals with a <italic toggle="yes">JAG1</italic> pathogenic variant who reproduce have milder disease than infants who present with the severe phenotype of neonatal cholestasis [Author, personal observation].</p>
        </sec>
        <sec id="alagille.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of ALGS was originally estimated at 1:70,000 live births; however, this is most likely an underestimate, as cases were ascertained solely on the basis of presence of neonatal liver disease [<xref ref-type="bibr" rid="alagille.REF.danks.1977.360">Danks et al 1977</xref>]. Based on the work by <xref ref-type="bibr" rid="alagille.REF.kamath.2003.891">Kamath et al [2003]</xref>, the authors estimate that the incidence of ALGS is 1:30,000-1:50,000 live births, but due to the variable phenotype, it remains underdiagnosed [<xref ref-type="bibr" rid="alagille.REF.kamath.2003.891">Kamath et al 2003</xref>]. The prevalence across populations appears to be stable.</p>
        </sec>
      </sec>
      <sec id="alagille.Genetically_Related_Allelic_Dis">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold><italic toggle="yes">JAG1</italic>.</bold> No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with mutation of <italic toggle="yes">JAG1</italic>. However, it should be noted that some individuals with pathogenic variants in <italic toggle="yes">JAG1</italic> may express only some of the features of ALGS and may not be recognized as having this diagnosis. The most clinically significant group is individuals with apparently isolated cardiac disease who have <italic toggle="yes">JAG1</italic> pathogenic variants [<xref ref-type="bibr" rid="alagille.REF.krantz.1998.1361">Krantz et al 1998</xref>, <xref ref-type="bibr" rid="alagille.REF.eldadah.2001.163">Eldadah et al 2001</xref>, <xref ref-type="bibr" rid="alagille.REF.bauer.2010.594">Bauer et al 2010</xref>, <xref ref-type="bibr" rid="alagille.REF.rauch.2010.321">Rauch et al 2010</xref>].</p>
        <p><bold><italic toggle="yes">NOTCH2</italic>.</bold> It should be noted that some individuals with pathogenic variants in <italic toggle="yes">NOTCH2</italic> may express only some of the features of ALGS and may not be recognized as having this diagnosis [<xref ref-type="bibr" rid="alagille.REF.kamath.2012a.138">Kamath et al 2012a</xref>].</p>
        <p>
          <bold>Germline pathogenic variants</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Hajdu-Cheney syndrome.</bold> Specific pathogenic variants in <italic toggle="yes">NOTCH2</italic> have recently been identified to cause Hajdu-Cheney syndrome, also known as serpentine fibula polycystic kidney syndrome. Hajdu-Cheney syndrome is an autosomal dominant disorder which causes focal bone destruction, osteoporosis, craniofacial dysmorphology, renal cysts, cleft palate, and cardiac defects. The <italic toggle="yes">NOTCH2</italic> pathogenic variants identified in individuals with Hadju-Cheney syndrome were all localized in the last exon (exon 34) of <italic toggle="yes">NOTCH2</italic>; these variants are predicted to disrupt the intracellular PEST (proline-glutamate-serine-threonine-rich) domain and decrease clearance of the notch intracellular domain, thus increasing Notch signaling [<xref ref-type="bibr" rid="alagille.REF.majewski.2011.1114">Majewski et al 2011</xref>, <xref ref-type="bibr" rid="alagille.REF.penton.2012.450">Penton et al 2012</xref>, <xref ref-type="bibr" rid="alagille.REF.zanotti.2012.886">Zanotti &#x00026; Canalis 2012</xref>].</p>
          </list-item>
        </list>
        <p>
          <bold>Somatic pathogenic variants</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Splenic marginal zone lymphoma (SMZL).</bold> Recurrent somatic pathogenic gain-of-function variants in <italic toggle="yes">NOTCH2</italic> have been identified in individuals with SMZL [<xref ref-type="bibr" rid="alagille.REF.kiel.2012.1553">Kiel et al 2012</xref>].</p>
          </list-item>
        </list>
      </sec>
      <sec id="alagille.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Neonatal cholestasis.</bold> More than 100 specific causes of neonatal cholestasis exist:</p>
        <list list-type="bullet">
          <list-item>
            <p>Treatable causes such as sepsis or <related-object link-type="booklink" source-id="gene" document-id="galactosemia" document-type="chapter">galactosemia</related-object> need to be considered first.</p>
          </list-item>
          <list-item>
            <p>A diisopropyl iminodiacetic acid (DISIDA) scan may identify cholestasis as a result of extrahepatic causes such as biliary atresia.</p>
          </list-item>
          <list-item>
            <p>Hepatic ultrasound examination can detect extrahepatic structural abnormalities such as choledochal cysts.</p>
          </list-item>
        </list>
        <p><bold>Bile duct paucity</bold> is not seen exclusively in Alagille syndrome (ALGS). Other causes of bile duct paucity include: idiopathic, metabolic disorders (<related-object link-type="booklink" source-id="gene" document-id="alpha1-a" document-type="chapter">alpha-1-antitrypsin deficiency</related-object>, hypopituitarism, <related-object link-type="booklink" source-id="gene" document-id="cf" document-type="chapter">cystic fibrosis</related-object>, trihydroxycoprostanic acid excess), chromosome abnormalities (Down syndrome), infectious diseases (congenital CMV, congenital rubella, congenital syphilis, hepatitis B), immunologic disorders (graft-versus-host disease, chronic hepatic allograft rejection, primary sclerosing cholangitis), and others (<related-object link-type="booklink" source-id="gene" document-id="pbd" document-type="chapter">Zellweger syndrome</related-object>, Ivemark syndrome). These can be distinguished from ALGS by history, by the presence of other findings, or by genetic testing.</p>
        <p>Other disorders associated with <bold>intrahepatic cholestasis</bold> include the autosomal recessive disorders <related-object link-type="booklink" source-id="gene" document-id="pfic" document-type="chapter">progressive familial intrahepatic cholestasis 1 and 2</related-object> (Byler syndrome), Norwegian cholestasis (Aagenaes syndrome), benign recurrent intrahepatic cholestasis (BRIC), and North American Indian cholestasis (NAIC). These conditions are largely confined to the liver; only ALGS demonstrates multi-organ system involvement.</p>
        <p><bold>Posterior embryotoxon</bold> is seen in Rieger syndrome, Bannayan-Riley-Ruvalcaba syndrome (one of the phenotypes of the <related-object link-type="booklink" source-id="gene" document-id="phts" document-type="chapter"><italic toggle="yes">PTEN</italic> hamartoma tumor syndrome</related-object>), and numerous other syndromes. It is also observed in 8%-15% of the general population. ALGS can be distinguished by the presence of other findings or by genetic testing.</p>
        <p><bold>Pulmonic vascular system abnormalities</bold> are seen in isolation as well as in syndromes such as <related-object link-type="booklink" source-id="gene" document-id="noonan" document-type="chapter">Noonan syndrome</related-object>, Watson syndrome (pulmonic stenosis and <related-object link-type="booklink" source-id="gene" document-id="nf1" document-type="chapter">neurofibromatosis type 1</related-object>), <related-object link-type="booklink" source-id="gene" document-id="leopard" document-type="chapter">LEOPARD syndrome</related-object>, Down syndrome, and <related-object link-type="booklink" source-id="gene" document-id="williams" document-type="chapter">Williams syndrome</related-object>. These other syndromes can be distinguished by other associated clinical findings and/or molecular genetic testing.</p>
        <p>Several of the <bold>cardiac defects</bold> described in ALGS, particularly ventricular septal defect and tetralogy of Fallot, are commonly seen in individuals with <related-object link-type="booklink" source-id="gene" document-id="gr_22q11deletion" document-type="chapter">deletion 22q11.2</related-object>. Individuals with this diagnosis have also been reported as having butterfly vertebrae and poor growth, two common features of ALGS. Liver disease is not part of the deletion 22q11.2 syndrome; testing for this deletion using the specific FISH probe distinguishes the two disorders [<xref ref-type="bibr" rid="alagille.REF.greenway.2009.931">Greenway et al 2009</xref>].</p>
        <p>See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/phenotypicSeries/PS118450">Alagille Syndrome: OMIM Phenotypic Series</ext-link> to view genes associated with this phenotype in OMIM.</p>
      </sec>
      <sec id="alagille.Management">
        <title>Management</title>
        <sec id="alagille.Evaluations_Following_Initial_D">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with Alagille syndrome (ALGS), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Evaluation by a gastroenterologist, including a full set of liver function tests, clotting studies and if necessary, serum bile acids, fat-soluble vitamin levels, a hepatic ultrasound, a technitium-99m-DISIDA scintiscan, and liver biopsy</p>
            </list-item>
            <list-item>
              <p>A full cardiac evaluation, including echocardiogram</p>
            </list-item>
            <list-item>
              <p>AP and lateral chest radiographs to evaluate for the presence of butterfly vertebrae</p>
            </list-item>
            <list-item>
              <p>An ophthalmologic examination to identify anterior chamber involvement</p>
            </list-item>
            <list-item>
              <p>Renal function testing and renal ultrasound examination (especially in the newborn period)</p>
            </list-item>
            <list-item>
              <p>Screening developmental evaluation, with more detailed evaluation if significant delays are identified</p>
            </list-item>
            <list-item>
              <p>Measurement of growth parameters and plotting on age-appropriate growth charts</p>
            </list-item>
            <list-item>
              <p>Medical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="alagille.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>A multidisciplinary approach to the management of individuals with ALGS is often beneficial because of the multisystem involvement. Evaluation by specialists in medical genetics, gastroenterology, nephrology, nutrition, cardiology, ophthalmology, liver transplantation, and child development may be indicated, depending on the age and specific difficulties of the individual [<xref ref-type="bibr" rid="alagille.REF.kamath.2010a.580">Kamath et al 2010a</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>Pruritus is considered the most severe of any pediatric liver disease. Pruritis and xanthomas have been successfully treated with choloretic agents (ursodeoxycholic acid) and other medications (cholestyramine, rifampin, naltrexone). Partial internal biliary diversion (PIBD) and ileal exclusions for individuals with Alagille syndrome have also been reported; however, while these procedures have the potential to relieve the intractable symptoms of liver disease (such as pruritis) and improve quality of life for those with ALGS, they are not thought to prevent the progression of liver disease [<xref ref-type="bibr" rid="alagille.REF.emerick.2002.1501">Emerick &#x00026; Whitington 2002</xref>, <xref ref-type="bibr" rid="alagille.REF.mattei.2006.104">Mattei et al 2006</xref>, <xref ref-type="bibr" rid="alagille.REF.dingemann.2012.251">Dingemann et al 2012</xref>, <xref ref-type="bibr" rid="alagille.REF.sheflinfindling.2012.1453">Sheflin-Findling et al 2012</xref>].</p>
            </list-item>
            <list-item>
              <p>Liver transplantation for end-stage liver disease has an 80.4% five-year survival rate, and results in improved liver function and some catch-up growth in 90% of affected individuals; however, the catch-up growth seen in post-transplanted individuals with Allagille syndrome is still less than that observed in individuals with other cholestatic liver diseases [<xref ref-type="bibr" rid="alagille.REF.quirostejeira.2000.582">Quiros-Tejeira et al 2000</xref>, <xref ref-type="bibr" rid="alagille.REF.kasahara.2003.2147">Kasahara et al 2003</xref>, <xref ref-type="bibr" rid="alagille.REF.pawlowska.2010.72">Pawlowska et al 2010</xref>]. In a recent study on survival following liver transplant in several disorders, Kamath et al showed that the one-year survival rate for individuals with ALGS was 87%, compared to a 96% one-year survival rate for the control group (individuals with biliary atresia). The lower success rate of liver transplantation in ALGS is probably most influenced by the severity of any coexisting cardiac disease, renal disease, or vascular involvement [<xref ref-type="bibr" rid="alagille.REF.kamath.2012c.940">Kamath et al 2012c</xref>]. Additionally, the effects of long-term immosuppressants on the evolution of the other organ systems involved, including vasculature, skeleton, and kidneys, remain largely unknown [<xref ref-type="bibr" rid="alagille.REF.englert.2006.154">Englert et al 2006</xref>, <xref ref-type="bibr" rid="alagille.REF.kamath.2010b.526">Kamath et al 2010b</xref>, <xref ref-type="bibr" rid="alagille.REF.shneider.2012.878">Shneider 2012</xref>]. Note: Since ALGS frequently presents with neonatal jaundice and can mimic biliary atresia, infants with ALGS may undergo an intraoperative cholangiogram and a Kasai procedure. However, a study by <xref ref-type="bibr" rid="alagille.REF.kaye.2010.319">Kaye et al [2010]</xref> demonstrated that the Kasai procedure does not benefit children with ALGS and may worsen the outcome [<xref ref-type="bibr" rid="alagille.REF.kaye.2010.319">Kaye et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p>Cardiac involvement is treated in a standard manner.</p>
            </list-item>
            <list-item>
              <p>Renal anomalies are treated in a standard manner.</p>
            </list-item>
            <list-item>
              <p>Vascular accidents should be treated in a standard manner.</p>
            </list-item>
            <list-item>
              <p>Head injuries and neurologic symptoms should be evaluated aggressively.</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic abnormalities rarely need intervention.</p>
            </list-item>
            <list-item>
              <p>Vertebral anomalies are rarely symptomatic.</p>
            </list-item>
          </list>
          <p>Note: <xref ref-type="bibr" rid="alagille.REF.elisofon.2010.759">Elisofon et al [2010]</xref> showed that health-related quality of life (HRQOL) in children with Alagille syndrome (ALGS) is impaired and that cardiac catheterization or surgery, mental health diagnoses, and poor sleep are associated with lower scores in children with ALGS [<xref ref-type="bibr" rid="alagille.REF.elisofon.2010.759">Elisofon et al 2010</xref>]. While surgeries and mental health diagnoses may be out of the control of physicians and care-givers, poor sleep in children with ALGS is often a result of severe pruritus, which can be improved with choloretic agents as discussed above.</p>
        </sec>
        <sec id="alagille.Prevention_of_Secondary_Complic">
          <title>Prevention of Secondary Complications</title>
          <p>The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Optimization of nutrition to maximize growth and development</p>
            </list-item>
            <list-item>
              <p>Close monitoring of plasma concentration of fat-soluble vitamins, nutritional optimization, and vitamin replacement therapy to maximize growth potential and prevent some of the developmental delay documented in early studies</p>
            </list-item>
            <list-item>
              <p>For those with splenomegaly or with known chronic liver disease, use of a spleen guard during activities</p>
            </list-item>
          </list>
        </sec>
        <sec id="alagille.Surveillance">
          <title>Surveillance</title>
          <p>Growth should be monitored using standard growth charts so that nutritional intake can be adjusted to need.</p>
          <p>Regular monitoring by cardiology, gastroenterology, and a nutritionist is appropriate.</p>
          <p>At this time, the efficacy of presymptomatic screening for vascular anomalies in individuals with ALGS has not been formally evaluated. The possibility of a vascular accident should be considered in any symptomatic individual and MRI, magnetic resonance angiography, and/or angiography to identify aneurysms, dissections, or bleeds should be pursued aggressively as warranted.</p>
        </sec>
        <sec id="alagille.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Contact sports should be avoided by all individuals, especially those with chronic liver disease, splenomegaly, and vascular involvement.</p>
          <p>Individuals with liver disease should avoid alcohol consumption.</p>
        </sec>
        <sec id="alagille.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>Given the medical problems of this condition and their variability, it is appropriate to assess first-degree relatives for manifestations of the disorder.</p>
          <list list-type="bullet">
            <list-item>
              <p>If a <italic toggle="yes">JAG1</italic> or <italic toggle="yes">NOTCH2</italic> pathogenic variant has been identified in a proband, at-risk relatives can be evaluated using genetic testing.</p>
            </list-item>
            <list-item>
              <p>If no <italic toggle="yes">JAG1</italic> or <italic toggle="yes">NOTCH2</italic> pathogenic variant has been identified, at-risk relatives can be assessed with measurement of liver enzymes, cardiac examination, eye examination, skeletal x-rays, and evaluation of facial features.</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="alagille.Related_Genetic_Counseling_Issu">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="alagille.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="alagille.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="alagille.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Alagille syndrome (ALGS) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="alagille.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Approximately 30%-50% of individuals diagnosed with ALGS have an affected parent.</p>
            </list-item>
            <list-item>
              <p>Approximately 50%-70% of affected individuals have ALGS as the result of a <italic toggle="yes">de novo</italic> pathogenic variant [<xref ref-type="bibr" rid="alagille.REF.krantz.1998.1361">Krantz et al 1998</xref>, <xref ref-type="bibr" rid="alagille.REF.crosnier.1999.1141">Crosnier et al 1999</xref>, <xref ref-type="bibr" rid="alagille.REF.spinner.2001.18">Spinner et al 2001</xref>].</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a simplex case (i.e., an individual with ALGS and no known family history of ALGS) include liver function testing, cardiac evaluation, radiographs of the spine, ophthalmologic examination, and evaluation of facial features by a clinical geneticist.</p>
              <list list-type="bullet">
                <list-item>
                  <p>If the proband has an identifiable <italic toggle="yes">JAG1</italic> or <italic toggle="yes">NOTCH2</italic> pathogenic variant, molecular genetic testing of the parents is recommended.</p>
                </list-item>
                <list-item>
                  <p>If the proband shows a microdeletion of 20p12 on FISH testing, FISH testing of both parents is appropriate.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent is affected, the risk to sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low; however, multiple instances of a child inheriting ALGS from an apparently unaffected, phenotypically normal parent who was mosaic for a 20p microdeletion have been reported [<xref ref-type="bibr" rid="alagille.REF.laufercahana.2002.190">Laufer-Cahana et al 2002</xref>].</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">JAG1</italic> or <italic toggle="yes">NOTCH2</italic> pathogenic variant or deletion present in the proband cannot be found in either parent, the risk to sibs is low, but greater than that of the general population because of the possibility of germline mosaicism [<xref ref-type="bibr" rid="alagille.REF.giannakudis.2001.209">Giannakudis et al 2001</xref>].</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Offspring of an individual with ALGS have a 50% chance of inheriting the <italic toggle="yes">JAG1</italic> or <italic toggle="yes">NOTCH2</italic> pathogenic variant. The clinical manifestations in the offspring cannot be predicted and range from mild or subclinical features to severe heart and/or liver disease.</p>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the status of the proband's parents. If a parent is affected, his or her family members are at risk.</p>
        </sec>
        <sec id="alagille.Related_Genetic_Counseling_Issu">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="alagille.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When the parents of a proband with an autosomal dominant condition are unaffected, it is likely that the proband has a <italic toggle="yes">de novo</italic> pathogenic variant. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling&#x000a0;(including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="alagille.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p><bold>Molecular genetic testing.</bold> If the <italic toggle="yes">JAG1</italic> or <italic toggle="yes">NOTCH2</italic> pathogenic variant has been identified in the family, prenatal diagnosis for pregnancies at increased risk may be available from a a clinical laboratory that offers either testing of the gene or custom prenatal testing. Prenatal testing cannot predict the occurrence or severity of clinical manifestations.</p>
          <p><bold>Fetal ultrasound examination.</bold> In fetuses at 50% risk for ALGS, fetal echocardiogram may detect a significant structural defect of the heart; however, a normal fetal echocardiogram does not eliminate the possibility of ALGS or the possibility of a structural cardiac abnormality in the fetus.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the pathogenic variant has been identified in an affected family member.</p>
        </sec>
      </sec>
      <sec id="alagille.Resources">
        <title>Resources</title>
      </sec>
      <sec id="alagille.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p>
          <bold>
            <italic toggle="yes">JAG1</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">JAG1</italic> comprises 26 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="alagille" object-id="alagille.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Benign allelic variants.</bold> A number of benign variants (benign polymorphisms) that are not expected to result in a disease phenotype have been reported [<xref ref-type="bibr" rid="alagille.REF.krantz.1998.1361">Krantz et al 1998</xref>, <xref ref-type="bibr" rid="alagille.REF.crosnier.1999.1141">Crosnier et al 1999</xref>, <xref ref-type="bibr" rid="alagille.REF.spinner.2001.18">Spinner et al 2001</xref>].</p>
        <p><bold>Pathogenic allelic variants.</bold> More than 226 pathogenic variants have been identified in individuals with Alagille syndrome (ALGS) (~70% of those tested). Pathogenic variant types have included: deletion of the entire <italic toggle="yes">JAG1</italic> gene (4%), protein-truncating variants (frameshift and nonsense) (69%), pathogenic splicing variants (16%), and pathogenic missense variants (11%) [<xref ref-type="bibr" rid="alagille.REF.krantz.1998.1361">Krantz et al 1998</xref>, <xref ref-type="bibr" rid="alagille.REF.crosnier.1999.1141">Crosnier et al 1999</xref>, <xref ref-type="bibr" rid="alagille.REF.krantz.1999.56">Krantz et al 1999</xref>, <xref ref-type="bibr" rid="alagille.REF.onouchi.1999.235">Onouchi et al 1999</xref>, <xref ref-type="bibr" rid="alagille.REF.pilia.1999.394">Pilia et al 1999</xref>, <xref ref-type="bibr" rid="alagille.REF.crosnier.2000.574">Crosnier et al 2000</xref>, <xref ref-type="bibr" rid="alagille.REF.heritage.2000.408">Heritage et al 2000</xref>, <xref ref-type="bibr" rid="alagille.REF.colliton.2001.151">Colliton et al 2001</xref>, <xref ref-type="bibr" rid="alagille.REF.giannakudis.2001.209">Giannakudis et al 2001</xref>, <xref ref-type="bibr" rid="alagille.REF.ropke.2003.100">Ropke et al 2003</xref>]. Two thirds of the detectable pathogenic variants are identified by sequencing exons 1-6, 9, 12, 17, 20, 23, 24; the remainder are identified by sequencing the other exons. <italic toggle="yes">JAG1</italic> pathogenic variants are distributed throughout the gene with no clustering or mutational 'hot spots&#x02019;.</p>
        <p><bold>Normal gene product.</bold> Jagged-1 is a cell surface protein that functions as a ligand for the neurogenic locus notch homolog protein 2 <italic toggle="yes">(</italic>Notch) transmembrane receptors, key signaling molecules found on the surface of a variety of cells. Jagged-1 and Notch are components of the highly conserved Notch signaling pathway, which has been studied primarily in the fruit fly <italic toggle="yes">Drosophila melanogaster</italic> and in the nematode <italic toggle="yes">Caenorhabditis elegans</italic>. It functions in many cell types throughout development to regulate cell fate decisions. The name Notch derives from the characteristic notched wing found in fruit flies carrying only one functional copy of the gene. Homozygous pathogenic variants in <italic toggle="yes">Notch</italic> in fruit flies are lethal, and the flies show hypertrophy of the nervous system. The finding that mutation of <italic toggle="yes">JAG1</italic> causes ALGS indicates that Notch signaling is important in the development of the affected organs (i.e., liver, heart, kidney, facial structures, skeleton, and eye).</p>
        <p>There are multiple other Notch pathway genes involved in human disease [<xref ref-type="bibr" rid="alagille.REF.louvi.2012.473">Louvi &#x00026; Artavanis-Tsakonas 2012</xref>, <xref ref-type="bibr" rid="alagille.REF.penton.2012.450">Penton et al 2012</xref>]. Notch1 is inactivated by chromosome translocations in T lymphoblastic leukemias. Additionally, pathogenic variants in <italic toggle="yes">NOTCH1</italic> have been associated with isolated cardiac defects [<xref ref-type="bibr" rid="alagille.REF.greenway.2009.931">Greenway et al 2009</xref>]. Pathogenic variants in <italic toggle="yes">NOTCH3</italic> cause cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (<related-object link-type="booklink" source-id="gene" document-id="cadasil" document-type="chapter">CADASIL</related-object>). Pathogenic variants in exon 34 of <italic toggle="yes">NOTCH2</italic> cause Hajdu-Chenney syndrome [<xref ref-type="bibr" rid="alagille.REF.simpson.2011.303">Simpson et al 2011</xref>] (see <xref ref-type="sec" rid="alagille.Genetically_Related_Allelic_Dis">Genetically Related Disorders</xref>). Finally, pathogenic variants in the Notch pathway genes <italic toggle="yes">DLL3</italic>, <italic toggle="yes">HES7</italic>, <italic toggle="yes">LFNG</italic>, and <italic toggle="yes">MESP2</italic> have been shown to cause <related-object link-type="booklink" source-id="gene" document-id="spondylocostal-d" document-type="chapter">spondylocostal dysostosis</related-object> (SCD) and spondylothoracic dysostosis (STD) [<xref ref-type="bibr" rid="alagille.REF.turnpenny.2007.1456">Turnpenny et al 2007</xref>, <xref ref-type="bibr" rid="alagille.REF.dunwoodie.2009.329">Dunwoodie 2009</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Haploinsufficiency of Jagged-1 has been shown to result in ALGS as evidenced by those individuals with ALGS who have a cytogenetically detectable deletion of chromosome 20p12 encompassing the entire <italic toggle="yes">JAG1</italic> gene. Haploinsufficiency is likely the pathogenic mechanism in the majority of cases of ALGS, as most pathogenic variants result in or predict a severely truncated protein product, lacking the transmembrane region necessary for the protein product to embed in the cell membrane and participate in signaling. Evidence has been presented in <italic toggle="yes">Drosophila</italic> that some of these truncated products can be secreted from the cell and can interfere with the signaling in a dominant-negative manner; however, no such evidence has been identified in humans to date. The identification of a significant number of pathogenic missense variants (11%) [<xref ref-type="bibr" rid="alagille.REF.krantz.1998.1361">Krantz et al 1998</xref>, <xref ref-type="bibr" rid="alagille.REF.crosnier.1999.1141">Crosnier et al 1999</xref>] may indicate important regions of <italic toggle="yes">JAG1</italic>, and it is possible that the resultant gene products may be produced and targeted to the cell surface and may exert a dominant-negative effect. However, in a few cases studied, the proteins produced as a result of missense variants are improperly trafficked through the cell, and therefore fail to appear on the cell surface, resulting in functional haploinsufficiency [<xref ref-type="bibr" rid="alagille.REF.morrissette.2001.405">Morrissette et al 2001</xref>, <xref ref-type="bibr" rid="alagille.REF.iso.2003.543">Iso et al 2003</xref>, <xref ref-type="bibr" rid="alagille.REF.penton.2012.450">Penton et al 2012</xref>].</p>
        <p>
          <bold>
            <italic toggle="yes">NOTCH2</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">NOTCH2</italic> comprises 34 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="alagille" object-id="alagille.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Benign allelic variants.</bold> A number of benign variants (benign polymorphisms) that are not expected to result in a disease phenotype have been reported [<xref ref-type="bibr" rid="alagille.REF.mcdaniell.2006.169">McDaniell et al 2006</xref>, <xref ref-type="bibr" rid="alagille.REF.kamath.2012a.138">Kamath et al 2012a</xref>].</p>
        <p><bold>Pathogenic allelic variants.</bold> See <xref ref-type="table" rid="alagille.T.selected_notch2_pathogenic_va">Table 3</xref>. Ten different pathogenic variants have been identified in eleven unrelated families with clinical features of ALGS including one splice site alteration, one frameshift variant, one nonsense variant, and seven missense variants (<xref ref-type="table" rid="alagille.T.selected_notch2_pathogenic_va">Table 3</xref>). The splice site alteration (c.5930-1G&#x0003e;A) results in the loss of the splice acceptor of exon 33, which causes aberrant splicing out of this exon, followed by a premature termination codon. The frameshift variant, p.Ser856LeufsTer17 (see <xref ref-type="table" rid="alagille.T.selected_notch2_pathogenic_va">Table 3</xref>), is located in exon 16 and 18. The nonsense variant (p.Arg2003Ter) has been seen in two unrelated families. The seven pathogenic missense variants shown in <xref ref-type="table" rid="alagille.T.selected_notch2_pathogenic_va">Table 3</xref> are localized in both the EGF-like repeats of the extracellular domain and the ANK repeats of the intracellular domain of Notch 2 [<xref ref-type="bibr" rid="alagille.REF.kamath.2012a.138">Kamath et al 2012a</xref>, <xref ref-type="bibr" rid="alagille.REF.penton.2012.450">Penton et al 2012</xref>].</p>
        <table-wrap id="alagille.T.selected_notch2_pathogenic_va" position="anchor" orientation="portrait">
          <label>Table 3. </label>
          <caption>
            <p>Selected <italic toggle="yes">NOTCH2</italic> Pathogenic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                <th id="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1331G&#x0003e;A</td>
                <td headers="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys444Tyr</td>
                <td headers="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_3" rowspan="10" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/24041034">NM_024408.2</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/24041035">NP_077719.2</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1117T&#x0003e;C</td>
                <td headers="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys373Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1180C&#x0003e;T</td>
                <td headers="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro394Ser</td>
              </tr>
              <tr>
                <td headers="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1147C&#x0003e;T</td>
                <td headers="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro383Ser</td>
              </tr>
              <tr>
                <td headers="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.5857C&#x0003e;T</td>
                <td headers="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg1953Cys</td>
              </tr>
              <tr>
                <td headers="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.5858G&#x0003e;A</td>
                <td headers="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg1953His</td>
              </tr>
              <tr>
                <td headers="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.5930-1G&#x0003e;A</td>
                <td headers="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
              </tr>
              <tr>
                <td headers="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1438T&#x0003e;C</td>
                <td headers="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys480Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2566_2567delAG</td>
                <td headers="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ser856LeufsTer17</td>
              </tr>
              <tr>
                <td headers="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.6007C&#x0003e;T</td>
                <td headers="hd_h_alagille.T.selected_notch2_pathogenic_va_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg2003Ter</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> Neurogenic locus notch homolog protein 2 (Notch 2) encodes a member of the Notch family of transmembrane receptors. The Notch receptors (Notch 1, 2, 3, and 4 in humans) share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple, different domain types. The intracellular portion includes seven ankyrin (ANK) repeats that are known to be protein-protein interaction motifs. Notch family members play a role in a variety of developmental processes by controlling cell fate decisions. The Notch signaling network is an evolutionarily conserved intercellular signaling pathway that regulates interactions between physically adjacent cells. This protein is cleaved in the trans-Golgi network, and presented on the cell surface as a heterodimer. The protein functions as a receptor for membrane-bound ligands and may play a role in vascular, renal, and hepatic development.</p>
        <p><bold>Abnormal gene product.</bold> The eleven pathogenic variants identified to date occur in different parts of the Notch 2 protein. Six are in the EGF-like repeats (extracellular domain) and four are in the ankyrin (ANK) repeats. Functional data and/or computer predictions are available for the reported pathogenic missense variants [<xref ref-type="bibr" rid="alagille.REF.kamath.2012a.138">Kamath et al 2012a</xref>].</p>
      </sec>
      <sec id="alagille.References">
        <title>References</title>
        <sec id="alagille.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="alagille.Literature_Cited.reflist0">
            <ref id="alagille.REF.arvay.2005.146">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arvay</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zemel</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallagher</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rovner</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulberg</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stallings</surname>
                    <given-names>VA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haber</surname>
                    <given-names>BA</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Body composition of children aged 1 to 12 years with biliary atresia or Alagille syndrome.</article-title>
                <source>J Pediatr Gastroenterol Nutr</source>
                <volume>40</volume>
                <fpage>146</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">15699687</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.bales.2010.66">
              <mixed-citation publication-type="journal"><person-group><name name-style="western"><surname>Bales</surname><given-names>CB</given-names></name><name name-style="western"><surname>Kamath</surname><given-names>BM</given-names></name><name name-style="western"><surname>Munoz</surname><given-names>PS</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>A</given-names></name></person-group>PIccoli DA, Spinner NB, Horn D, Shults J, Leonard MB, Grimberg A, Loomes KM<year>2010</year><article-title>Pathologic lower extremity fractures in children with Alagille syndrome.</article-title><source>J Pediatr Gastroenterol Nutr.</source><volume>51</volume><fpage>66</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">20453673</pub-id></mixed-citation>
            </ref>
            <ref id="alagille.REF.bauer.2010.594">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bauer</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laney</surname>
                    <given-names>AO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerfen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrissette</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woyciechowski</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garvarini</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loomes</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krantz</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urban</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gelb</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldmuntz</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis.</article-title>
                <source>Hum Mutat.</source>
                <volume>31</volume>
                <fpage>594</fpage>
                <lpage>601</lpage>
                <pub-id pub-id-type="pmid">20437614</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.colliton.2001.151">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Colliton</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bason</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccoli</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krantz</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Mutation analysis of Jagged1 (JAG1) in Alagille syndrome patients.</article-title>
                <source>Hum Mutat</source>
                <volume>17</volume>
                <fpage>151</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">11180599</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.crosnier.2000.574">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Crosnier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Attie-Bitach</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Encha-Razavi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Audollent</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soudy</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hadchouel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meunier-Rotival</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vekemans</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>JAGGED1 gene expression during human embryogenesis elucidates the wide phenotypic spectrum of Alagille syndrome.</article-title>
                <source>Hepatology</source>
                <volume>32</volume>
                <fpage>574</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">10960452</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.crosnier.1999.1141">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Crosnier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Driancourt</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raynaud</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dhorne-Pollet</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pollet</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hadchouel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meunier-Rotival</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Mutations in JAGGED1 gene are predominantly sporadic in Alagille syndrome.</article-title>
                <source>Gastroenterology</source>
                <volume>116</volume>
                <fpage>1141</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10220506</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.danks.1977.360">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Danks</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jack</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogers</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>AL</given-names>
                  </name>
                </person-group>
                <year>1977</year>
                <article-title>Studies of the aetiology of neonatal hepatitis and biliary atresia.</article-title>
                <source>Arch Dis Child</source>
                <volume>52</volume>
                <fpage>360</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">559475</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.dingemann.2012.251">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dingemann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumann</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petersen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lentze</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ure</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Ileal exclusion for intractable pruritus in Alagille syndrome.</article-title>
                <source>Eur J Pediatr Surg.</source>
                <year>2012</year>
                <volume>22</volume>
                <fpage>251</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">22573255</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.dunwoodie.2009.329">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dunwoodie</surname>
                    <given-names>SL</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>The role of Notch in patterning the human vertebral column.</article-title>
                <source>Curr Opin Genet Dev.</source>
                <volume>19</volume>
                <fpage>329</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">19608404</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.eldadah.2001.163">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eldadah</surname>
                    <given-names>ZA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamosh</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biery</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montgomery</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elkins</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dietz</surname>
                    <given-names>HC</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Familial Tetralogy of Fallot caused by mutation in the jagged1 gene.</article-title>
                <source>Hum Mol Genet</source>
                <volume>10</volume>
                <fpage>163</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11152664</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.elisofon.2010.759">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Elisofon</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emerick</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sinacore</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alonso</surname>
                    <given-names>EM</given-names>
                  </name>
                </person-group>
                <article-title>Health status of patients with Alagille syndrome.</article-title>
                <source>J Pediatr Gastroenterol Nutr.</source>
                <year>2010</year>
                <volume>51</volume>
                <fpage>759</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">20948445</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.elkoofy.2011.199">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>El-Koofy</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Mahdy</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahmy</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Hennawy</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farag</surname>
                    <given-names>MY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Karaksy</surname>
                    <given-names>HM</given-names>
                  </name>
                </person-group>
                <article-title>Alagille syndrome: clinical and ocular pathognomonic features.</article-title>
                <source>Eur J Ophthalmol.</source>
                <year>2011</year>
                <volume>21</volume>
                <fpage>199</fpage>
                <lpage>206</lpage>
                <pub-id pub-id-type="pmid">20677167</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.emerick.2005.99">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Emerick</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krantz</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamath</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darling</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burrowes</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whitington</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccoli</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Intracranial vascular abnormalities in patients with Alagille syndrome.</article-title>
                <source>J Pediatr Gastroenterol Nutr</source>
                <volume>41</volume>
                <fpage>99</fpage>
                <lpage>107</lpage>
                <pub-id pub-id-type="pmid">15990638</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.emerick.1999.822">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Emerick</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rand</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldmuntz</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krantz</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccoli</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Features of Alagille syndrome in 92 patients: frequency and relation to prognosis.</article-title>
                <source>Hepatology</source>
                <volume>29</volume>
                <fpage>822</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10051485</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.emerick.2002.1501">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Emerick</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whitington</surname>
                    <given-names>PF</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Partial external biliary diversion for intractable pruritus and xanthomas in Alagille syndrome.</article-title>
                <source>Hepatology</source>
                <volume>35</volume>
                <fpage>1501</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12029636</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.englert.2006.154">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Englert</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grabhorn</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burdelski</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ganschow</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Liver transplantation in children with Alagille syndrome: indications and outcome.</article-title>
                <source>Pediatr Transplant</source>
                <volume>10</volume>
                <fpage>154</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16573599</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.giannakudis.2001.209">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Giannakudis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ropke</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kujat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krajewska-Walasek</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fryns</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bankier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amor</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlicker</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansmann</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Parental mosaicism of JAG1 mutations in families with Alagille syndrome.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>9</volume>
                <fpage>209</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">11313761</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.goldman.2011.193">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goldman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pranikoff</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Biliary disease in children.</article-title>
                <source>Curr Gastroenterol Rep.</source>
                <year>2011</year>
                <volume>13</volume>
                <fpage>193</fpage>
                <lpage>201</lpage>
                <pub-id pub-id-type="pmid">21225381</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.greenway.2009.931">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Greenway</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pereira</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DePalma</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Israel</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mesquita</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ergul</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conta</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korn</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCarroll</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorham</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gabriel</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Altshuler</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quintanilla-Dieck Mde</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Artunduaga</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eavey</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plenge</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shadick</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weinblatt</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jager</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hafler</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breitbart</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seidman</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seidman</surname>
                    <given-names>CE</given-names>
                  </name>
                </person-group>
                <article-title>De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot.</article-title>
                <source>Nat Genet.</source>
                <year>2009</year>
                <volume>41</volume>
                <fpage>931</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19597493</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.guegan.2012.33">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guegan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stals</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Day</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnpenny</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>JAG1 mutations are found in approximately one third of patients presenting with only one or two clinical features of Alagille syndrome.</article-title>
                <source>Clin Genet.</source>
                <year>2012</year>
                <volume>82</volume>
                <fpage>33</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">21752016</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.gurkan.1999.416">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gurkan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emre</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fishbein</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brady</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Millis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Birnbaum</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim-Schluger</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheiner</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Unsuspected bile duct paucity in donors for living-related liver transplantation: two case reports.</article-title>
                <source>Transplantation</source>
                <volume>67</volume>
                <fpage>416</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10030288</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.heritage.2000.408">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Heritage</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacMillan</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colliton</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>GJ</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Jagged1 (JAG1) mutation detection in an Australian Alagille syndrome population.</article-title>
                <source>Hum Mutat</source>
                <volume>16</volume>
                <fpage>408</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">11058898</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.hingorani.1999.330">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hingorani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nischal</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bentley</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vivian</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mieli-Vergani</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aclimandos</surname>
                    <given-names>WA</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Ocular abnormalities in Alagille syndrome.</article-title>
                <source>Ophthalmology</source>
                <volume>106</volume>
                <fpage>330</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9951486</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.iso.2003.543">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Iso</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamamori</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kedes</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Notch signaling in vascular development.</article-title>
                <source>Arterioscler Thromb Vasc Biol</source>
                <volume>23</volume>
                <fpage>543</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">12615665</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.kamath.2003.891">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kamath</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bason</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccoli</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krantz</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Consequences of JAG1 mutations.</article-title>
                <source>J Med Genet</source>
                <volume>40</volume>
                <fpage>891</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">14684686</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.kamath.2012a.138">
              <mixed-citation publication-type="journal"><person-group><name name-style="western"><surname>Kamath</surname><given-names>BM</given-names></name><name name-style="western"><surname>Baur</surname><given-names>RC</given-names></name><name name-style="western"><surname>Loomes</surname><given-names>KM</given-names></name><name name-style="western"><surname>Chao</surname><given-names>G</given-names></name><name name-style="western"><surname>Gerfen</surname><given-names>J</given-names></name><name name-style="western"><surname>Hutchinson</surname><given-names>A</given-names></name><name name-style="western"><surname>Hardikar</surname><given-names>W</given-names></name><name name-style="western"><surname>Hirschfield</surname><given-names>G</given-names></name><name name-style="western"><surname>Jara</surname><given-names>P</given-names></name><name name-style="western"><surname>Krantz</surname><given-names>ID</given-names></name><name name-style="western"><surname>Lapunzina</surname><given-names>P</given-names></name><name name-style="western"><surname>Leonard</surname><given-names>LD</given-names></name><name name-style="western"><surname>Ling</surname><given-names>S</given-names></name><name name-style="western"><surname>Lee Ng</surname><given-names>V</given-names></name></person-group>Le Hoang Phuc, Piccoli DA, Spinner NB<year>2012a</year><article-title>NOTCH2 mutations in Alagille syndrome.</article-title><source>J Med Genet</source><volume>49</volume><fpage>138</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">22209762</pub-id></mixed-citation>
            </ref>
            <ref id="alagille.REF.kamath.2002a.171">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kamath</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loomes</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oakey</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krantz</surname>
                    <given-names>ID</given-names>
                  </name>
                </person-group>
                <year>2002a</year>
                <article-title>Supernumerary digital flexion creases: an additional clinical manifestation of Alagille syndrome.</article-title>
                <source>Am J Med Genet</source>
                <volume>112</volume>
                <fpage>171</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12244551</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.kamath.2010a.580">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kamath</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loomes</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccoli</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <article-title>Medical management of Alagille syndrome.</article-title>
                <source>J Pediatr Gastroenterol Nutr.</source>
                <year>2010a</year>
                <volume>50</volume>
                <fpage>580</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">20479679</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.kamath.2010b.526">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kamath</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munoz</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bab</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccoli</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <year>2010b</year>
                <article-title>A longitudinal study to identify laboratory predictors of liver disease outcome in Alagille syndrome.</article-title>
                <source>J Pediatr Gastroenterol Nutr.</source>
                <volume>50</volume>
                <fpage>526</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">20421762</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.kamath.2012b.85">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kamath</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Podkameni</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hutchinson</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerfen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krantz</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccoli</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loomes</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyers</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2012b</year>
                <article-title>Renal anomalies in Alagille syndrome: A disease-defining feature.</article-title>
                <source>Am J Med Genet Part A</source>
                <volume>158A</volume>
                <fpage>85</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">22105858</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.kamath.2004.1354">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kamath</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emerick</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chudley</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Booth</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccoli</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krantz</surname>
                    <given-names>ID</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality.</article-title>
                <source>Circulation</source>
                <volume>109</volume>
                <fpage>1354</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14993126</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.kamath.2002b.176">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kamath</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stolle</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bason</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colliton</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccoli</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krantz</surname>
                    <given-names>ID</given-names>
                  </name>
                </person-group>
                <year>2002b</year>
                <article-title>Craniosynostosis in Alagille syndrome.</article-title>
                <source>Am J Med Genet</source>
                <volume>112</volume>
                <fpage>176</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">12244552</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.kamath.2009.371">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kamath</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiel</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gai</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conlin</surname>
                    <given-names>LK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munoz</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glessner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warthen</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaikh</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mihci</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccoli</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grant</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hakonarson</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krantz</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>SNP array mapping of chromosome 20p deletions: genotypes, phenotypes, and copy number variation.</article-title>
                <source>Hum Mutat.</source>
                <volume>30</volume>
                <fpage>371</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19058200</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.kamath.2012c.940">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kamath</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yin</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anand</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rand</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alonso</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bucuvalas</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Studies of Pediatric Liver Transplantation. Outcomes of liver transplantation for patients with Alagille syndrome: the studies of pediatric liver transplantation experience.</article-title>
                <source>Liver Transpl.</source>
                <year>2012c</year>
                <volume>18</volume>
                <fpage>940</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">22454296</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.kasahara.2003.2147">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kasahara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiuchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inomata</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uryuhara</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakamoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujimoto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogura</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oike</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Living-related liver transplantation for Alagille syndrome.</article-title>
                <source>Transplantation</source>
                <volume>75</volume>
                <fpage>2147</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">12829928</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.kaye.2010.319">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaye</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rand</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munoz</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flake</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamath</surname>
                    <given-names>BM</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Effect of Kasai procedure on hepatic outcome in Alagille syndrome.</article-title>
                <source>J Pediatr Gastroenterol Nutr.</source>
                <volume>51</volume>
                <fpage>319</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">20601899</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.kiel.2012.1553">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kiel</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velusamy</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Betz</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weigelin</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiang</surname>
                    <given-names>MY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huebner-Chan</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bailey</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhagat</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miranda</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahler</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Medeiros</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elenitoba-Johnson</surname>
                    <given-names>KS</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma.</article-title>
                <source>J Exp Med.</source>
                <volume>209</volume>
                <fpage>1553</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">22891276</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.krantz.1998.1361">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Krantz</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colliton</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rand</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccoli</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Spectrum and frequency of jagged1 (JAG1) mutations in Alagille syndrome patients and their families.</article-title>
                <source>Am J Hum Genet</source>
                <volume>62</volume>
                <fpage>1361</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9585603</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.krantz.1999.56">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Krantz</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colliton</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tinkel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zackai</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccoli</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldmuntz</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Jagged1 mutations in patients ascertained with isolated congenital heart defects.</article-title>
                <source>Am J Med Genet</source>
                <volume>84</volume>
                <fpage>56</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">10213047</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.laufercahana.2002.190">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Laufer-Cahana</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krantz</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bason</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccoli</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Alagille syndrome inherited from a phenotypically normal mother with a mosaic 20p microdeletion.</article-title>
                <source>Am J Med Genet</source>
                <volume>112</volume>
                <fpage>190</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">12244554</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.le_caignec.2002.180">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Le Caignec</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lefevre</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schott</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaventre</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gayet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calais</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moisan</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Familial deafness, congenital heart defects, and posterior embryotoxon caused by cysteine substitution in the first epidermal-growth-factor-like domain of jagged 1.</article-title>
                <source>Am J Hum Genet</source>
                <volume>71</volume>
                <fpage>180</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12022040</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.leonard.2014">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chao</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loomes</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                </person-group>
                <article-title>Clinical utility gene card for: Alagille Syndrome (ALGS).</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2014</year>
                <volume>22</volume>
                <issue>3</issue>
                <pub-id pub-id-type="pmid">23881058</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.lin.2012.1005">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoang</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hutchinson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chao</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerfen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loomes</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krantz</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamath</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Alagille syndrome in a Vietnamese cohort: Mutation analysis and assessment of facial features.</article-title>
                <source>Am J Med Genet Part A</source>
                <volume>158A</volume>
                <fpage>1005</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">22488849</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.louvi.2012.473">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Louvi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Artavanis-Tsakonas</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>Notch and disease: a growing field.</article-title>
                <source>Semin Cell Dev Biol.</source>
                <year>2012</year>
                <volume>23</volume>
                <fpage>473</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">22373641</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.lu.2003.1065">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrissette</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Conditional JAG1 mutation shows the developing heart is more sensitive than developing liver to JAG1 dosage.</article-title>
                <source>Am J Hum Genet</source>
                <volume>72</volume>
                <fpage>1065</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">12649809</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.majewski.2011.1114">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Majewski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartzentruber</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caqueret</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patry</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marcadier</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fryns</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boycott</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ste-Marie</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKiernan</surname>
                    <given-names>FE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marik</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Esch</surname>
                    <given-names>H</given-names>
                  </name>
                  <collab>FORGE Canada Consortium</collab>
                </person-group>
                <article-title>Michaud JL, Samuels ME. Mutations in NOTCH2 in families with Hajdu-Cheney syndrome.</article-title>
                <source>Hum Mutat.</source>
                <year>2011</year>
                <volume>32</volume>
                <fpage>1114</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21681853</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.makino.2012.1445">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Makino</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohkubo</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tampo</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Optical coherence tomography and fundus autofluorescence imaging study of chorioretinal atrophy involving the macula in Alagille syndrome.</article-title>
                <source>Clin Ophthalmol.</source>
                <volume>6</volume>
                <fpage>1445</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">23055661</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.mattei.2006.104">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mattei</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Allmen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccoli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rand</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Relief of intractable pruritis in Alagille syndrome by partial external biliary diversion.</article-title>
                <source>J Pediatr Surg</source>
                <volume>41</volume>
                <fpage>104</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16410117</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.mcdaniell.2006.169">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McDaniell</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warthen</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanchez-Lara</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pai</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krantz</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccoli</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>NOTCH2 Mutations Cause Alagille Syndrome, a Heterogeneous Disorder of the Notch Signaling Pathway.</article-title>
                <source>Am J Hum Genet</source>
                <volume>79</volume>
                <fpage>169</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">16773578</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.mcelhinney.2002.2567">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McElhinney</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krantz</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bason</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccoli</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emerick</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldmuntz</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome.</article-title>
                <source>Circulation</source>
                <volume>106</volume>
                <fpage>2567</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">12427653</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.morrissette.2001.405">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morrissette</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colliton</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Defective intracellular transport and processing of JAG1 missense mutations in Alagille syndrome.</article-title>
                <source>Hum Mol Genet</source>
                <volume>10</volume>
                <fpage>405</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">11157803</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.narula.2006.348">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Narula</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gifford</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steggall</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lloyd</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Mourik</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mckiernan</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willshaw</surname>
                    <given-names>HE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelly</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Visual loss and idiopathic intracranial hypertension in children with Alagille syndrome.</article-title>
                <source>J Pediatr Gastroenterol Nutr</source>
                <volume>43</volume>
                <fpage>348</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">16954958</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.onouchi.1999.235">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Onouchi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurahashi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tajiri</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ida</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okada</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Genetic alterations in the JAG1 gene in Japanese patients with Alagille syndrome.</article-title>
                <source>J Hum Genet</source>
                <volume>44</volume>
                <fpage>235</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10429362</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.pawlowska.2010.72">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pawlowska</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Socha</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jankowska</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <article-title>Factors affecting catch-up growth after liver transplantation in children with cholestatic liver diseases.</article-title>
                <source>Ann Transplant.</source>
                <year>2010</year>
                <volume>15</volume>
                <fpage>72</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">20305323</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.penton.2012.450">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Penton</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                </person-group>
                <article-title>Notch signaling in human development and disease.</article-title>
                <source>Semin Cell Dev Biol.</source>
                <year>2012</year>
                <volume>23</volume>
                <fpage>450</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">22306179</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.pilia.1999.394">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pilia</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macis</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frau</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crisponi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbera</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colombo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frediani</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gatti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iorio</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marazzi</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marcellini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Musumeci</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nebbia</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vajro</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruffa</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zancan</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cao</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeVirgilis</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Jagged-1 mutation analysis in Italian Alagille syndrome patients.</article-title>
                <source>Hum Mutat.</source>
                <year>1999</year>
                <volume>14</volume>
                <fpage>394</fpage>
                <lpage>400</lpage>
                <pub-id pub-id-type="pmid">10533065</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.quirostejeira.2000.582">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Quiros-Tejeira</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ament</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heyman</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenthal</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gornbein</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDiarmid</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vargas</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <article-title>Does liver transplantation affect growth pattern in Alagille syndrome?</article-title>
                <source>Liver Transpl.</source>
                <year>2000</year>
                <volume>6</volume>
                <fpage>582</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10980057</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.rauch.2010.321">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rauch</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofbeck</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zweier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zink</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trautmann</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoyer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaulitz</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rauch</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>omprehensive genotypey-phenotype analysis in 230 patients with tetralogy of Fallot.</article-title>
                <source>J Med Genet.</source>
                <volume>47</volume>
                <fpage>321</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">19948535</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.rocha.2012.125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rocha</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soro</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leit&#x000e3;o</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silva</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le&#x000e3;o</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Moyamoya vascular pattern in Alagille syndrome.</article-title>
                <source>Pediatr Neurol.</source>
                <year>2012</year>
                <volume>47</volume>
                <fpage>125</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">22759690</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.ropke.2003.100">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ropke</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kujat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graber</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giannakudis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansmann</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Identification of 36 novel Jagged1 (JAG1) mutations in patients with Alagille syndrome.</article-title>
                <source>Hum Mutat</source>
                <volume>21</volume>
                <fpage>100</fpage>
                <pub-id pub-id-type="pmid">12497640</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.salem.2012.1300">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Salem</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruguiere</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iserin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guiochon-Mantel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plouin</surname>
                    <given-names>PF</given-names>
                  </name>
                </person-group>
                <article-title>Hypertension and aortorenal disease in Alagille syndrome.</article-title>
                <source>J Hypertens.</source>
                <year>2012</year>
                <volume>30</volume>
                <fpage>1300</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">22525199</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.sanderson.2002.114">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sanderson</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haigh</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sidhu</surname>
                    <given-names>PS</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Vertebral anomalies in children with Alagille syndrome: an analysis of 50 consecutive patients.</article-title>
                <source>Pediatr Radiol</source>
                <volume>32</volume>
                <fpage>114</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11819079</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.sheflinfindling.2012.1453">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sheflin-Findling</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henderling</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kerkar</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iyer</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Partial internal biliary diversion for Alagille syndrome: case report and review of the literature.</article-title>
                <source>J Pediatr Surg.</source>
                <year>2012</year>
                <volume>47</volume>
                <fpage>1453</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">22813814</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.shneider.2012.878">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shneider</surname>
                    <given-names>BL</given-names>
                  </name>
                </person-group>
                <article-title>Liver transplantation for Alagille syndrome: the jagged edge.</article-title>
                <source>Liver Transpl.</source>
                <year>2012</year>
                <volume>18</volume>
                <fpage>878</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">22639390</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.simpson.2011.303">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Simpson</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Irving</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asilmaz</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gray</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dafou</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elmslie</surname>
                    <given-names>FV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mansour</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holder</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brain</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burton</surname>
                    <given-names>BK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pauli</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aftimos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holder-Espinasse</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robertson</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drake</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trembath</surname>
                    <given-names>RC</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss.</article-title>
                <source>Nat Genet.</source>
                <year>2011</year>
                <volume>43</volume>
                <fpage>303</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">21378985</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.spinner.2001.18">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colliton</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crosnier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krantz</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hadchouel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meunier-Rotival</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Jagged1 mutations in Alagille syndrome.</article-title>
                <source>Hum Mutat</source>
                <volume>17</volume>
                <fpage>18</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">11139239</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.subramaniam.2011.84">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Subramaniam</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knisely</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Portmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qureshi</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aclimandos</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karani</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <article-title>Diagnosis of Alagille syndrome-25 years of experience at King's College Hospital.</article-title>
                <source>J Pediatr Gastroenterol Nutr.</source>
                <year>2011</year>
                <volume>52</volume>
                <fpage>84</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21119543</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.turnpenny.2007.1456">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Turnpenny</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alman</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cornier</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giampietro</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offiah</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tassy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pourqui&#x000e9;</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kusumi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunwoodie</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Abnormal vertebral segmentation and the notch signaling pathway in man.</article-title>
                <source>Dev Dyn.</source>
                <year>2007</year>
                <volume>236</volume>
                <fpage>1456</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">17497699</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.turnpenny.2012.251">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Turnpenny</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Alagille syndrome: pathogenesis, diagnosis and management.</article-title>
                <source>Eur J Hum Genet.</source>
                <volume>3</volume>
                <fpage>251</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21934706</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.warthen.2006.436">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Warthen</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamath</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrissette</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanchez</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccoli</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krantz</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Jagged1 (JAG1) mutations in Alagille syndrome: increasing the mutation detection rate.</article-title>
                <source>Hum Mutat</source>
                <volume>27</volume>
                <fpage>436</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">16575836</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.woolfenden.1999.505">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Woolfenden</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albers</surname>
                    <given-names>GW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinberg</surname>
                    <given-names>GK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahn</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnston</surname>
                    <given-names>DCC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrell</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Moyamoya syndrome in children with Alagille syndrome: additional evidence of a vasculopathy.</article-title>
                <source>Pediatrics</source>
                <volume>103</volume>
                <fpage>505</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9925853</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.zanotti.2012.886">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zanotti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canalis</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Notch and the skeleton.</article-title>
                <source>Mol Cell Biol.</source>
                <volume>30</volume>
                <fpage>886</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">19995916</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="alagille.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="alagille.Suggested_Reading.reflist0">
            <ref id="alagille.REF.antsaklis.2011.450">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Antsaklis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anastasakis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mousiolis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papantoniou</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mesogitis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daskalakis</surname>
                    <given-names>G.</given-names>
                  </name>
                </person-group>
                <article-title>Alagille syndrome.</article-title>
                <source>J Obstet Gynaecol.</source>
                <year>2011</year>
                <volume>31</volume>
                <fpage>450</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">21627437</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.kamath.2010.11">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kamath</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwarz</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hadzi&#x00107;</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <article-title>Alagille syndrome and liver transplantation.</article-title>
                <source>J Pediatr Gastroenterol Nutr.</source>
                <year>2010</year>
                <volume>50</volume>
                <fpage>11</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19949348</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.meunierrotival.2005">
              <mixed-citation publication-type="webpage">Meunier-Rotival M, Hadchouel M. Alagille syndrome (ALGS). <italic toggle="yes">Atlas of Genetics and Cytogenetics in Oncology and Haematology</italic>. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://atlasgeneticsoncology.org/Kprones/AlagilleID10090.html">online</ext-link>. 2005. Accessed 2-23-16.</mixed-citation>
            </ref>
            <ref id="alagille.REF.rahmoune.2011.355">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rahmoune</surname>
                    <given-names>FC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruy&#x000e8;re</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tecsy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benhamou</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Alagille syndrome and pregnancy: anesthetic management for cesarean section.</article-title>
                <source>Int J Obstet Anesth.</source>
                <year>2011</year>
                <volume>20</volume>
                <fpage>355</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">21925870</pub-id>
              </element-citation>
            </ref>
            <ref id="alagille.REF.shaffer">
              <mixed-citation publication-type="webpage">Shaffer LG, Ledbetter DH, Lupski JR. Molecular cytogenetics of contiguous gene syndromes: mechanisms and consequences of gene dosage imbalance. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID).</italic> Chap 65. New York, NY: McGraw-Hill. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com/content.aspx?sectionid=62670708&#x00026;bookid=971">online</ext-link>. Accessed 2-23-16.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="alagille.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="alagille.Author_History">
          <title>Author History</title>
          <p>Lynn D Bason, MS, CGC; Children's Hospital of Philadelphia (2000-2003) Anne L Hutchinson, BS; Children's Hospital of Philadelphia (2010-2013)Binita M Kamath, MBBChir MRCP; The Hospital for Sick Children (2003-2013) Ian D Krantz, MD (2000-present) Laura D Leonard, BA (2013-present)Nancy B Spinner, PhD (2000-present)</p>
        </sec>
        <sec id="alagille.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>28 February 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>20 July 2010 (cd) Revision: prenatal testing available for <italic toggle="yes">NOTCH2</italic> mutations</p>
            </list-item>
            <list-item>
              <p>11 May 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>2 July 2007 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>18 May 2006 (cd) Revision: <italic toggle="yes">NOTCH2</italic> mutations identified in individuals with Alagille syndrome</p>
            </list-item>
            <list-item>
              <p>18 February 2005 (mr) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>2 February 2004 (ns) Author revisions</p>
            </list-item>
            <list-item>
              <p>16 June 2003 (cd) Revision: DNA and RNA sequence analysis available on clinical basis</p>
            </list-item>
            <list-item>
              <p>4 February 2003 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>19 May 2000 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>January 2000 (ns) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="alagille.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Typical facial features of Alagille syndrome. Note broad forehead, deep-set eyes, and pointed chin.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="alagille-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
